• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫治疗应答的 SARS-CoV-2 感染加重发作性眼球运动性肌阵挛-小脑共济失调综合征。

Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome.

机构信息

Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.

Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA; Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Mult Scler Relat Disord. 2021 May;50:102855. doi: 10.1016/j.msard.2021.102855. Epub 2021 Feb 23.

DOI:10.1016/j.msard.2021.102855
PMID:33677410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7899919/
Abstract

The global pandemic of SARS-CoV-2 has been known to have diverse neurologic complications among adult patients. The neurologic effects of SARS-CoV-2 in the pediatric population is poorly described, especially in those with rare underlying neurologic conditions. We describe the first known case of SARS-CoV-2 in a pediatric patient with refractory opsoclonus-myoclonus syndrome. A 25-month-old female with progressive opsoclonus-myoclonus syndrome secondary to metastatic neuroblastoma status-post resection and chemotherapy presented with worsening opsoclonus, tremor, and breakthrough seizures. She had no fever or respiratory symptoms at presentation. Urine catecholamines were unchanged, with low suspicion for tumor recurrence. She was found to have SARS-CoV-2 via nasopharnygeal PCR assay. She received intravenous immunoglobulin and dexamethasone therapy with improvement in opsoclonus-myoclonus syndrome symptoms and was discharged home at her neurologic baseline. Patients with opsoclonus-myoclonus syndrome may present with exacerbation of symptoms in the context of SARS-CoV-2. This case describes a sentinel report of a child with opsoclonus-myoclonus syndrome presenting with worsening symptoms with concomitant SARS-CoV-2. Improvement in symptoms was achieved with standard of care therapies.

摘要

SARS-CoV-2 全球大流行已被证实可导致成年患者出现多种神经系统并发症。SARS-CoV-2 对儿科人群的神经系统影响描述甚少,尤其是在那些伴有罕见潜在神经系统疾病的患儿中。我们描述了首例已知的 SARS-CoV-2 感染合并难治性眼-口-肌阵挛综合征的儿科患者。一名 25 月龄的女性,因转移性神经母细胞瘤行切除和化疗后继发难治性眼-口-肌阵挛综合征,出现进行性眼-口-肌阵挛、震颤和突破性癫痫发作。就诊时无发热或呼吸道症状。尿儿茶酚胺未见变化,肿瘤复发的可能性较低。通过鼻咽拭子 PCR 检测发现 SARS-CoV-2 阳性。给予静脉注射免疫球蛋白和地塞米松治疗后,眼-口-肌阵挛综合征症状改善,患儿出院时神经系统状态恢复基线水平。眼-口-肌阵挛综合征患者可能因 SARS-CoV-2 出现症状恶化。本病例描述了一例以眼-口-肌阵挛综合征症状加重为表现的患儿,同时合并 SARS-CoV-2 感染。经标准治疗后症状改善。

相似文献

1
Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome.免疫治疗应答的 SARS-CoV-2 感染加重发作性眼球运动性肌阵挛-小脑共济失调综合征。
Mult Scler Relat Disord. 2021 May;50:102855. doi: 10.1016/j.msard.2021.102855. Epub 2021 Feb 23.
2
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.Opsoclonus-Myoclonus-Ataxia 综合征(OMAS)与 SARS-CoV-2 感染相关:具有良性预后的感染后神经系统并发症。
Tremor Other Hyperkinet Mov (N Y). 2021 Feb 10;11:7. doi: 10.5334/tohm.580.
3
Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2.严重急性呼吸综合征冠状病毒 2 型中的眼震-肌阵挛-共济失调综合征。
J Neurovirol. 2021 Jun;27(3):501-503. doi: 10.1007/s13365-021-00974-0. Epub 2021 Mar 31.
4
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.Opsoclonus-myoclonus 综合征,COVID-19 的一种感染后神经并发症:病例系列及文献复习。
J Neurovirol. 2021 Feb;27(1):26-34. doi: 10.1007/s13365-020-00941-1. Epub 2021 Jan 25.
5
Myoclonus status revealing COVID 19 infection.肌阵挛状态揭示 COVID-19 感染。
Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22.
6
Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.一名儿童患眼阵挛-肌阵挛综合征、神经母细胞瘤和胰岛素依赖型糖尿病:一位独特的患者。
Pediatr Neurol. 2016 Feb;55:68-70. doi: 10.1016/j.pediatrneurol.2015.09.021. Epub 2015 Oct 23.
7
Opsoclonus-Myoclonus-Ataxia Syndrome Due to Covid-19.新冠病毒导致的眼震-肌阵挛-共济失调综合征。
Cerebellum. 2024 Jun;23(3):1245-1248. doi: 10.1007/s12311-023-01610-9. Epub 2023 Oct 9.
8
Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.感染后 SARS-CoV-2 动眼神经危象-肌阵挛-小脑共济失调综合征。
J Neuroophthalmol. 2022 Jun 1;42(2):251-255. doi: 10.1097/WNO.0000000000001498. Epub 2021 Dec 30.
9
Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.两例与 COVID-19 相关的伴有视频的严重共济失调-肌阵挛综合征病例。
Neurol Neurochir Pol. 2021;55(3):310-313. doi: 10.5603/PJNNS.a2021.0036. Epub 2021 Jun 7.
10
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].[与非转移性神经母细胞瘤相关的眼阵挛-肌阵挛综合征。长期生存。法国儿科肿瘤学家协会的研究]
Arch Pediatr. 2000 Jun;7(6):621-8. doi: 10.1016/s0929-693x(00)80129-3.

引用本文的文献

1
Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients.小儿斜视性眼阵挛-肌阵挛共济失调综合征综述
Children (Basel). 2024 Mar 19;11(3):367. doi: 10.3390/children11030367.
2
Neurological Manifestations of Coronavirus Disease 2019 and Mpox in Pediatric Patients and Their Management: A State-of-the-Art Systematic Review.新型冠状病毒病 2019 与猴痘在儿科患者中的神经表现及其治疗:最新系统评价。
Pediatr Neurol. 2023 Sep;146:65-78. doi: 10.1016/j.pediatrneurol.2023.05.011. Epub 2023 May 19.
3
Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的眼阵挛-肌阵挛-共济失调综合征
Neuroophthalmology. 2022 Dec 15;47(1):1-6. doi: 10.1080/01658107.2022.2128378. eCollection 2023.
4
Para-Infectious Opsoclonus Myoclonus Syndrome with COVID-19.伴有新型冠状病毒肺炎的副感染性眼阵挛-肌阵挛综合征
Ann Indian Acad Neurol. 2022 May-Jun;25(3):546-548. doi: 10.4103/aian.aian_773_21. Epub 2022 Feb 14.
5
Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.新冠后眼阵挛-肌阵挛综合征:来自巴基斯坦的一例病例报告。
Front Neurol. 2021 Jun 7;12:672524. doi: 10.3389/fneur.2021.672524. eCollection 2021.